The S&P 500 Clinches Another Record
The S&P 500 closed above 6,300 for the first time as traders look for signs of resilience in earnings amid trade turmoil. Wall Street's biggest bull at Wells Fargo is as optimistic as ever, expecting the benchmark to notch double-digit gains in the second half thanks to Big Tech. The yen extended gains, but strategists warned of risks to the currency and Japanese government bonds after Prime Minister Shigeru Ishiba's election defeat.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Top Analyst Calls UnitedHealth a 'Top Pick' Ahead of Earnings
July 22 - UnitedHealth Group (NYSE:UNH) has tumbled roughly 42% year?to?date, driven by rising Medicare Advantage costs, a surprise CEO exit, withdrawn guidance and a Department of Justice probe. However, ahead of its July 29 Q2 earnings, Bernstein analyst Lance Wilkes tapped UNH as a 'Top Pick,' saying the pullback creates an attractive entry point. He noted the stock trades at about 13.5 times forward earnings, below its ten?year average. Warning! GuruFocus has detected 4 Warning Sign with UNH. Wilkes cut his 2025 EPS estimate by 10% to reflect reserve strengthening and cost pressures in individual and Medicaid segments, plus a cleanup of OptumHealth risk contracts. Yet he projects earnings per share could double by 2029, implying a 19% compound annual growth rate. The analyst expects cost normalization to begin in Medicaid in Q3 and in Medicare Advantage in early 2026 as utilization patterns stabilize. He also highlighted a hardening pricing environment for government managed?care plans as a margin tailwind. Is UNH Stock a Buy? Based on the one year price targets offered by 24 analysts, the average target price for UnitedHealth Group Inc is $375.46 with a high estimate of $677.00 and a low estimate of $270.00. The average target implies a upside of +33.08% from the current price of $282.14. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release
Stock futures have inched higher, driven by optimism over potential U.S.-EU trade progress and the start of a busy earnings week featuring top tech names like Alphabet and Tesla. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In commodities and bonds, yields eased slightly as investors embraced calming signals: Treasury yields dipped to 4.38% on the 10-year, the dollar weakened, and gold held steady amid easing tariff jitters. In pre-market trading, S&P 500 futures rose 0.19%, Nasdaq futures rose 0.18% and Dow futures rose 0.21% Check out this morning's top movers from around Wall Street, compiled by The Fly and subscribe to the pre-market Fly By on YouTube. HIGHER – Dynamix (DYNX) up 30% after The Ether Machine announced its public launch through a definitive business combination agreement between The Ether Reserve and the company Block (XYZ) up 9% after S&P 500 addition UP AFTER EARNINGS – Cleveland-Cliffs (CLF) up 4% Verizon (VZ) up 3% Domino's Pizza (DPZ) up 3% Roper Technologies (ROP) up 1% HBT Financial (HBT) up 1% LOWER – Evotec (EVO) down 12% after cutting its full-year revenue outlook Sarepta (SRPT) down 9% after reporting the FDA has placed a clinical hold on the company's investigational gene therapy clinical trials for limb girdle muscular dystrophy Stellantis (STLA) down 1% after reporting preliminary first half results and Q2 shipments Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on DYNX: Disclaimer & DisclosureReport an Issue The Ether Machine to go public through Dynamix business combination Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
QuantumScape Stock Plunges Ahead of Earnings. Should You Buy the Dip in QS Stock, or Steer Clear?
QuantumScape (QS) stock is coming off of a remarkable rally, reaching a new 52-week high of $15.03 on July 18 to cap off a nine-day win streak leading up to its Q2 earnings release on July 23. The company's recent success is largely attributed to the groundbreaking integration of its Cobra separator process into baseline cell production, which has dramatically improved manufacturing efficiency by a factor of 25 compared to previous methods. The technological advancement has not only streamlined production but also reduced equipment requirements and operational footprint, contributing to the battery stock's staggering 268% rise from its April lows. More News from Barchart Opendoor Stock Is Surging Higher in a Frenzied Retail Rally. How Should You Play OPEN Shares Here? This Penny Stock Wants to Become the MicroStrategy of Dogecoin Robinhood Stock Stumbles as S&P 500 Inclusion Is Once Again Off the Table for HOOD Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. QS Stock is Set to Slide Again Today However, the recently high-flying momentum stock is currently on pace to continue Monday's sharp reversal into a second session. In premarket trading, QS has collapsed by 9.5% on heavy volume, on pace to add to yesterday's 14.5% decline. QuantumScape stock is now below its upper Bollinger Band again, after briefly breaking out above this technical level. Additionally, the 14-day Relative Strength Index (RSI) stands at 63.46, retreating from a surge into deeply overbought territory earlier this month. What's Driving Growth at QuantumScape? While QuantumScape maintains a strong financial position, with $860 million in liquidity extending into late 2028, the company remains pre-revenue. For its second quarter, due out after Wednesday night's close, analysts expect QS to show improvement with a projected loss of $0.20 per share, compared to a loss of $0.25 per share last year. A strategic partnership with Volkswagen's (VWAGY) PowerCo battery arm continues to be a crucial element in QuantumScape's commercialization strategy, positioning QS to potentially license its technology for mass production of electric vehicle (EV) battery cells. QuantumScape is progressing toward customer sample shipments and field testing of QSE-5 modules in 2026, marking important milestones in its development timeline. More broadly, global EV sales are projected to exceed 20 million units in 2025, with the battery market expected to nearly triple production to 377,000 units in the same year. However, supply chain vulnerabilities persist - particularly as it relates to critical minerals and battery materials, where China maintains dominant control over 70% of global lithium supply and processing capacity. Should You Buy the Dip in QS Stock Ahead of Earnings? Despite this week's pullback, QS stock's current price-to-book ratio near 7.8x appears stretched for a development-stage company, raising valuation concerns. While the company's progress in addressing key EV market challenges of range anxiety and charging speed continues to attract investor attention, the significant gap between market enthusiasm and fundamental business metrics suggests careful consideration is warranted. With 8 analysts in coverage, the consensus rating on Wall Street is a cautious 'Hold,' with an average price target of $4.79 and a high price target of $8.00 - both of which are a discount to Monday's close at $12.52. Given the heightened volatility in QS ahead of earnings, investors may prefer to give this stock a wide berth until the Wednesday night report provides more clarity on QuantumScape's financial metrics and future outlook. This article was created with the support of automated content tools from our partners at Together, our financial data and AI solutions help us to deliver more informed market headline analysis to readers faster than ever. On the date of publication, Elizabeth H. Volk did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
